In this next episode, Professor Pinar Topsever discusses the risk factors for CKD in T2D, how to recognise and diagnose CKD in patients with T2D, and the barriers to recognition and diagnosis in practice.

This episode is part of the Independent Medical Education program entitled, 'T2D & CKD: Putting evidence into practice'. This independent medical educational program will support the multidisciplinary team (MDT) to proactively identify and manage patients with CKD and T2D whilst incorporating the latest clinical guidelines. In a series of vodcasts, our expert faculty will explain best practices for the identification, classification and management of CKD in T2D, drawing on recent advances in therapies and insights from a patient with these comorbidities.

To learn more about the full program, visit https://ckd-t2d.ime.springerhealthcare.com/

The information and data provided in this program was updated and correct at the time of the program development, but may be subject to change. This educational activity is intended for an international audience of non-US and non-UK HCPs.

This program is supported by an educational grant from Novo Nordisk A/S.

In our first episode, Tina Vilsbøll provides an overview of diabetic kidney disease (DKD) and the diabetes-cardio-kidney spectrum, as she discusses the importance of proactive identification and management.

This episode is part of the Independent Medical Education program entitled, 'T2D & CKD: Putting evidence into practice'. This independent medical educational program will support the multidisciplinary team (MDT) to proactively identify and manage patients with CKD and T2D whilst incorporating the latest clinical guidelines. In a series of vodcasts, our expert faculty will explain best practices for the identification, classification and management of CKD in T2D, drawing on recent advances in therapies and insights from a patient with these comorbidities.

To learn more about the full program, visit https://ckd-t2d.ime.springerhealthcare.com/

The information and data provided in this program was updated and correct at the time of the program development, but may be subject to change. This educational activity is intended for an international audience of non-US and non-UK HCPs.

This program is supported by an educational grant from Novo Nordisk A/S.

In this episode, Dr. Eugene Wright, Jr. dives into several sessions from the recent ADA meeting held in Orlando, Florida cpvering topics including New Technology- Equity and Access; The Role of the Interdisciplinary Team in Technology Onboarding in Primary Care; CGM New Technology; and CGM Implementation in Primary Care Practices

This program is made possible thanks to an independent educational grant from Abbott

Dr. Solange Peters, a renowned medical oncologist specializing in thoracic cancers, presents a detailed case study of a 45-year-old male diagnosed with stage 1B ALK-positive NSCLC during a routine screening. This case study delves into the complexities of diagnostic procedures and the rationale behind choosing specific treatment pathways. This episode underscores the critical role of vigilant monitoring and tailored treatment plans based on comprehensive molecular profiling.

This series of 3 podcasts is accredited for 0.25 AMA Type 1 Credit(s) To learn more about the full program, visit targeted-therapies-lung-cancer.ime.springerhealthcare.com for additional resources, including the webinar and downloadable patient case studies.

This program is made possible thanks to an independent educational grant from Roche and Illumina.

REFERENCES

In this episode, Dr. Lizza Hendriks, MD, PhD, delves into a challenging case involving a 40-year-old male with a history of psychosis. Despite being asymptomatic and off medication, he presents with concerning symptoms: a persistent cough, dyspnea, and a chest X-ray revealing a tumor in the left perihilar region. PET CT imaging further identifies multiple small lung nodules, a peripheral left tumor, and bone metastasis. Learn about diagnostic challenges, tissue-based testing, surgical interventions, choosing targeted therapies, and how brain imaging considerations are crucial for optimal management.

This series of 3 podcasts is accredited for 0.25 AMA Type 1 Credit(s) To learn more about the full program, visit targeted-therapies-lung-cancer.ime.springerhealthcare.com for additional resources, including the webinar and downloadable patient case studies.

This program is made possible thanks to an independent educational grant from Roche and Illumina.

REFERENCES

In this episode, Dr. Jamie L. Schneider, delves into the practical considerations for targeted therapy in ALK-rearranged non-small cell lung cancer (NSCLC) through an engaging patient case commentary. Join her as she explores the comprehensive diagnostic and treatment approach for a 54-year-old female patient presenting with advanced ALK-positive NSCLC.

This series of 3 podcasts is accredited for 0.25 AMA Type 1 Credit(s) To learn more about the full program, visit targeted-therapies-lung-cancer.ime.springerhealthcare.com for additional resources, including the webinar and downloadable patient case studies.

This program is made possible thanks to an independent educational grant from Roche and Illumina.

References

In this episode, Kris Kowdley meets with patient Sabrina Reeser as they discuss the patient experience of treatment for PBC, including treatment challenges, variability in doctor-patient communication and involvement in clinical trials.

Access a free, downloadable summary of their conversation to print and use in your practice at LINK TBC

This episode is part of the Independent Medical Education program entitled, 'Improving PBC outcomes by prioritising patients' needs'. This expert-led program will allow you to effectively evaluate treatment response in your patients, and make informed decisions on individualized patient management strategies, regarding therapy response, symptom management, clinical guidelines, and new advances in the PBC treatment landscape.

To learn more about the full program, visit pbc.ime.springerhealthcare.com

This program is made possible thanks to an independent educational grant from Ipsen.

In this episode, Dr. Rozalina McCoy dives into three sessions from the recent ATTD meeting held in Florence, Italy: Parallel Session 2: CGM Diabetes Quality Measures; Parallel Session 20: CGM Guided Precision Diabetes Management; and Parallel Session 3: Hypoglycemia – Any Progress?

This program is made possible thanks to an independent educational grant from Abbott

In this episode, David Jones meets with patient and patient advocate Mo Christie as they discuss the patient experience for PBC, including the burden of the disease and its impact on quality of life, with special reference to the common, and commonly misunderstood symptom, itch.

This episode is part of the Independent Medical Education program entitled, 'Improving PBC outcomes by prioritising patients' needs'. This expert-led program will allow you to effectively evaluate treatment response in your patients, and make informed decisions on individualized patient management strategies, regarding therapy response, symptom management, clinical guidelines, and new advances in the PBC treatment landscape.

To learn more about the full program, visit pbc.ime.springerhealthcare.com

This program is made possible thanks to an independent educational grant from Ipsen.

In this episode, Kris Kowdley and David Jones share their insights on the evolving landscape of Primary Biliary Cholangitis (PBC), including new and upcoming therapy options, and how these may change practice for the disease.

This episode is part of the Independent Medical Education program entitled, 'Improving PBC outcomes by prioritising patients' needs'. This expert-led program will allow you to effectively evaluate treatment response in your patients, and make informed decisions on individualized patient management strategies, regarding therapy response, symptom management, clinical guidelines, and new advances in the PBC treatment landscape.

To learn more about the full program, visit pbc.ime.springerhealthcare.com

This program is made possible thanks to an independent educational grant from Ipsen.